As of May 27, 2025, Oncternal Therapeutics Inc (ONCT) reports a Graham Number of N/A.
Graham Number calculates a stock's intrinsic value based on earnings and book value, aiding in spotting undervalued investments.
Comparing Oncternal Therapeutics Inc's Graham Number to Peers
To better understand Oncternal Therapeutics Inc's position, it's useful to compare its Graham Number against industry peers. Below are selected comparisons:
| Company | Graham Number |
|---|---|
| Oncternal Therapeutics Inc (ONCT) | - |
| Regeneron Pharmaceuticals Inc (REGN) | 500.00 |
| Moderna Inc (MRNA) | 157.32 |
| Vertex Pharmaceuticals Inc (VRTX) | 146.93 |
| Amgen Inc (AMGN) | 43.25 |
| Oncorus Inc (ONCR) | 16.82 |
Compared to its competitors, Oncternal Therapeutics Inc's Graham Number is difficult to compare due to insufficient data.